Literature DB >> 28758902

GATA4 loss of function in liver cancer impedes precursor to hepatocyte transition.

Francis O Enane1, Wai Ho Shuen2, Xiaorong Gu1, Ebrahem Quteba1, Bartlomiej Przychodzen1, Hideki Makishima1, Juraj Bodo1, Joanna Ng2, Chit Lai Chee2, Rebecca Ba2, Lip Seng Koh2, Janice Lim2, Rachael Cheong2, Marissa Teo2, Zhenbo Hu1, Kwok Peng Ng1, Jaroslaw Maciejewski1, Tomas Radivoyevitch3, Alexander Chung4, London Lucien Ooi4, Yu Meng Tan4, Peng-Chung Cheow4, Pierce Chow4, Chung Yip Chan4, Kiat Hon Lim5, Lisa Yerian6, Eric Hsi6, Han Chong Toh2, Yogen Saunthararajah1.   

Abstract

The most frequent chromosomal structural loss in hepatocellular carcinoma (HCC) is of the short arm of chromosome 8 (8p). Genes on the remaining homologous chromosome, however, are not recurrently mutated, and the identity of key 8p tumor-suppressor genes (TSG) is unknown. In this work, analysis of minimal commonly deleted 8p segments to identify candidate TSG implicated GATA4, a master transcription factor driver of hepatocyte epithelial lineage fate. In a murine model, liver-conditional deletion of 1 Gata4 allele to model the haploinsufficiency seen in HCC produced enlarged livers with a gene expression profile of persistent precursor proliferation and failed hepatocyte epithelial differentiation. HCC mimicked this gene expression profile, even in cases that were morphologically classified as well differentiated. HCC with intact chromosome 8p also featured GATA4 loss of function via GATA4 germline mutations that abrogated GATA4 interactions with a coactivator, MED12, or by inactivating mutations directly in GATA4 coactivators, including ARID1A. GATA4 reintroduction into GATA4-haploinsufficient HCC cells or ARID1A reintroduction into ARID1A-mutant/GATA4-intact HCC cells activated hundreds of hepatocyte genes and quenched the proliferative precursor program. Thus, disruption of GATA4-mediated transactivation in HCC suppresses hepatocyte epithelial differentiation to sustain replicative precursor phenotype.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28758902      PMCID: PMC5669578          DOI: 10.1172/JCI93488

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  81 in total

1.  Myc inhibits p27-induced erythroid differentiation of leukemia cells by repressing erythroid master genes without reversing p27-mediated cell cycle arrest.

Authors:  Juan C Acosta; Nuria Ferrándiz; Gabriel Bretones; Verónica Torrano; Rosa Blanco; Carlos Richard; Brenda O'Connell; John Sedivy; M Dolores Delgado; Javier León
Journal:  Mol Cell Biol       Date:  2008-10-06       Impact factor: 4.272

2.  Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin.

Authors:  Qingqing Ding; Weiya Xia; Jaw-Ching Liu; Jer-Yen Yang; Dung-Fang Lee; Jiahong Xia; Geoffrey Bartholomeusz; Yan Li; Yong Pan; Zheng Li; Ralf C Bargou; Jun Qin; Chien-Chen Lai; Fuu-Jen Tsai; Chang-Hai Tsai; Mien-Chie Hung
Journal:  Mol Cell       Date:  2005-07-22       Impact factor: 17.970

Review 3.  Higher-Level Pathway Objectives of Epigenetic Therapy: A Solution to the p53 Problem in Cancer.

Authors:  Vamsidhar Velcheti; Tomas Radivoyevitch; Yogen Saunthararajah
Journal:  Am Soc Clin Oncol Educ Book       Date:  2017

4.  Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.

Authors:  K Nakayama; N Ishida; M Shirane; A Inomata; T Inoue; N Shishido; I Horii; D Y Loh; K Nakayama
Journal:  Cell       Date:  1996-05-31       Impact factor: 41.582

5.  Singapore Genome Variation Project: a haplotype map of three Southeast Asian populations.

Authors:  Yik-Ying Teo; Xueling Sim; Rick T H Ong; Adrian K S Tan; Jieming Chen; Erwin Tantoso; Kerrin S Small; Chee-Seng Ku; Edmund J D Lee; Mark Seielstad; Kee-Seng Chia
Journal:  Genome Res       Date:  2009-08-21       Impact factor: 9.043

Review 6.  The role of liver progenitor cells during liver regeneration, fibrogenesis, and carcinogenesis.

Authors:  Julia Köhn-Gaone; Jully Gogoi-Tiwari; Grant A Ramm; John K Olynyk; Janina E E Tirnitz-Parker
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-11-25       Impact factor: 4.052

7.  Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis.

Authors:  Fereshteh Parviz; Christine Matullo; Wendy D Garrison; Laura Savatski; John W Adamson; Gang Ning; Klaus H Kaestner; Jennifer M Rossi; Kenneth S Zaret; Stephen A Duncan
Journal:  Nat Genet       Date:  2003-07       Impact factor: 38.330

8.  Identification of functional mutations in GATA4 in patients with congenital heart disease.

Authors:  Erli Wang; Shuna Sun; Bin Qiao; Wenyuan Duan; Guoying Huang; Yu An; Shuhua Xu; Yufang Zheng; Zhixi Su; Xun Gu; Li Jin; Hongyan Wang
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

9.  Dynamic interaction between WT1 and BASP1 in transcriptional regulation during differentiation.

Authors:  Laura M Green; Kate J Wagner; Hayley A Campbell; Kelly Addison; Stefan G E Roberts
Journal:  Nucleic Acids Res       Date:  2008-12-02       Impact factor: 16.971

10.  Epigenetics of gene expression in human hepatoma cells: expression profiling the response to inhibition of DNA methylation and histone deacetylation.

Authors:  Luke O Dannenberg; Howard J Edenberg
Journal:  BMC Genomics       Date:  2006-07-19       Impact factor: 3.969

View more
  15 in total

Review 1.  Fetal Hemoglobin Induction by Epigenetic Drugs.

Authors:  Donald Lavelle; James Douglas Engel; Yogen Saunthararajah
Journal:  Semin Hematol       Date:  2018-04-22       Impact factor: 3.851

2.  GATA5 inhibits hepatocellular carcinoma cells malignant behaviours by blocking expression of reprogramming genes.

Authors:  Haipeng Feng; Mingyue Zhu; Ruizhu Zhang; Qiaoyun Wang; Wei Li; Xu Dong; Yi Chen; Yan Lu; Kun Liu; Bo Lin; Junli Guo; Mengsen Li
Journal:  J Cell Mol Med       Date:  2019-01-22       Impact factor: 5.310

3.  Transcription factor protein interactomes reveal genetic determinants in heart disease.

Authors:  Barbara Gonzalez-Teran; Maureen Pittman; Franco Felix; Reuben Thomas; Desmond Richmond-Buccola; Ruth Hüttenhain; Krishna Choudhary; Elisabetta Moroni; Mauro W Costa; Yu Huang; Arun Padmanabhan; Michael Alexanian; Clara Youngna Lee; Bonnie E J Maven; Kaitlen Samse-Knapp; Sarah U Morton; Michael McGregor; Casey A Gifford; J G Seidman; Christine E Seidman; Bruce D Gelb; Giorgio Colombo; Bruce R Conklin; Brian L Black; Benoit G Bruneau; Nevan J Krogan; Katherine S Pollard; Deepak Srivastava
Journal:  Cell       Date:  2022-02-18       Impact factor: 66.850

Review 4.  ARID1 proteins: from transcriptional and post-translational regulation to carcinogenesis and potential therapeutics.

Authors:  Olena Odnokoz; Cindy Wavelet-Vermuse; Shelby L Hophan; Serdar Bulun; Yong Wan
Journal:  Epigenomics       Date:  2021-04-23       Impact factor: 4.778

5.  Suppression of canonical TGF-β signaling enables GATA4 to interact with H3K27me3 demethylase JMJD3 to promote cardiomyogenesis.

Authors:  Andrew S Riching; Etienne Danis; Yuanbiao Zhao; Yingqiong Cao; Congwu Chi; Rushita A Bagchi; Brianna J Klein; Hongyan Xu; Tatiana G Kutateladze; Timothy A McKinsey; Peter M Buttrick; Kunhua Song
Journal:  J Mol Cell Cardiol       Date:  2020-12-24       Impact factor: 5.763

6.  Differentiation therapy and the mechanisms that terminate cancer cell proliferation without harming normal cells.

Authors:  Francis O Enane; Yogen Saunthararajah; Murray Korc
Journal:  Cell Death Dis       Date:  2018-09-06       Impact factor: 8.469

7.  Simultaneous in situ detection of protein expression of multiple tumor markers of circulating tumor cells and heteroploid of chromosome 8 in primary lung cancer.

Authors:  Hanqing Yao; Zhengdong Wang; Junjun Yang; Xingxiang Xu; Yong Song
Journal:  Ann Transl Med       Date:  2021-12

8.  A GATA4-regulated secretory program suppresses tumors through recruitment of cytotoxic CD8 T cells.

Authors:  Rupesh S Patel; Rodrigo Romero; Emma V Watson; Anthony C Liang; Megan Burger; Peter M K Westcott; Kim L Mercer; Roderick T Bronson; Eric C Wooten; Arjun Bhutkar; Tyler Jacks; Stephen J Elledge
Journal:  Nat Commun       Date:  2022-01-11       Impact factor: 17.694

9.  A tumor suppressor enhancing module orchestrated by GATA4 denotes a therapeutic opportunity for GATA4 deficient HCC patients.

Authors:  Feng Lu; Qian Zhou; Lu Liu; Guandi Zeng; Weimin Ci; Wanting Liu; Gong Zhang; Zhiyi Zhang; Peng Wang; Aiqun Zhang; Yunfei Gao; Lei Yu; Qingyu He; Liang Chen
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

Review 10.  Emerging BRAF Mutations in Cancer Progression and Their Possible Effects on Transcriptional Networks.

Authors:  Magdalena Śmiech; Paweł Leszczyński; Hidetoshi Kono; Christopher Wardell; Hiroaki Taniguchi
Journal:  Genes (Basel)       Date:  2020-11-12       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.